Related Experiment Video
Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Alzheimer's Imaging Consortium
David A Hoagey1, Nicole S McKay2, Qing Wang3
1Washington University in St. Louis, St. Louis, MO, USA.
This study shows how amyloid and tau proteins impact brain structure in Alzheimer's disease (AD). Diffusion MRI reveals distinct regional effects of amyloid and tau, offering early biomarkers for neurodegeneration.
Area of Science:
- Neuroimaging
- Neuropathology
- Biomarker Discovery
Background:
- Alzheimer's disease (AD) staging involves amyloid and tau progression, but their regional impact on neurodegeneration is debated.
- Diffusion MRI detects microstructural changes, aiding in early AD detection and subtype differentiation.
- This study investigates the relationship between regional amyloid and tau deposition and diffusion metrics at the gray/white matter interface.
Purpose of the Study:
- To analyze the impact of regional amyloid and tau burden on diffusion MRI metrics.
- To assess microstructural changes in neuronal health related to protein deposition in Alzheimer's disease.
- To explore the potential of diffusion imaging as an early indicator of neurodegenerative processes.
Main Methods:
- Utilized data from 354 participants from the Knight Alzheimer Disease Research Center.
- Processed T1-weighted, diffusion MRI, and amyloid/tau PET imaging data.
- Employed general linear models to assess regional effects of amyloid and tau Standardized Uptake Value Ratio (SUVR) on Fractional Anisotropy (FA) values.
Main Results:
- Amyloid burden showed broad effects on diffusion, increasing FA in frontal, parietal, and superior temporal cortices, mirroring typical amyloid deposition patterns.
- Tau accumulation demonstrated a focused impact, decreasing FA in medial temporal, occipital, and lateral frontal areas, consistent with tau spread patterns.
- Regionally differential effects of amyloid and tau on FA were observed, highlighting distinct microstructural impacts.
Conclusions:
- Diffusion imaging metrics are strongly associated with the spread of amyloid and tau biomarkers in Alzheimer's disease.
- Observed regional patterns in diffusion metrics correlate with the known spread of amyloid and tau in early AD stages.
- These findings suggest diffusion MRI can serve as an early indicator of myelin integrity or cytoarchitectural changes, improving biomarker specificity for neurodegeneration.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...